333 filings
ARS
2023 FY
PCRX
Pacira BioSciences Inc
22 Apr 24
Annual report to shareholders
4:20pm
DEFA14A
PCRX
Pacira BioSciences Inc
22 Apr 24
Additional proxy soliciting materials
4:17pm
DEF 14A
PCRX
Pacira BioSciences Inc
Definitive proxy
22 Apr 24
4:16pm
S-8
PCRX
Pacira BioSciences Inc
29 Feb 24
Registration of securities for employees
5:29pm
10-K
2023 FY
PCRX
Pacira BioSciences Inc
Annual report
29 Feb 24
3:33pm
8-K
tp1pryi
29 Feb 24
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
8:03am
8-K
a5qj8h3 37
4 Jan 24
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
5:02pm
8-K
5cmb0p8qu5kt
21 Dec 23
Pacira Appoints Frank D. Lee as Chief Executive Officer
7:33am
8-K
ztesb
2 Nov 23
Pacira BioSciences Reports Third Quarter 2023 Financial Results
8:01am
UPLOAD
hmwuzq5sr r34wdzv
24 Oct 23
Letter from SEC
12:00am
8-K
rbbjb0okj4 d7n47
10 Oct 23
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
8:02am
CORRESP
l7p68dga0ktml1h3qlpv
6 Oct 23
Correspondence with SEC
12:00am
8-K
zv3bta0e0gb vnh7xcc
26 Sep 23
Pacira BioSciences Announces Leadership Succession Plan
4:32pm
UPLOAD
jet5s4 1w9m
22 Sep 23
Letter from SEC
12:00am
8-K
quxhmm7c3hs8il o3xsm
11 Sep 23
Other Events
4:27pm
S-8
tn4v7z2ojxce6uago6tk
2 Aug 23
Registration of securities for employees
4:34pm
8-K
mi3cypc9afelisurtww
2 Aug 23
Pacira BioSciences Reports Second Quarter 2023 Financial Results
8:02am
8-K
x0keds1g etc
20 Jun 23
Departure of Directors or Certain Officers
4:25pm